课题基金 / 基金详情

项目摘要

项目成果

Paul G. Thomas的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):与B细胞不同,一旦完全成熟的T细胞离开胸腺,T细胞受体的谱系通常被认为是固定的。我们最近开发了一项技术,可以从小鼠和人类的单个细胞中检测成对的��T细胞受体的信息并对其进行排序。这一方法允许两个重要的观察:1)在急性和记忆免疫反应过程中,两条TCRA链转录信息的细胞比例显著不同;2)体内T细胞的克隆性谱系证明了外周受体的修订。采用创新的体外单细胞培养平台,独一无二 在活体模型中,包括条件性RAG缺陷小鼠和一组有价值的纵向人类样本,我们建议扩展这些观察,以评估对病毒感染的最佳T细胞反应需要固有的可塑性外周系统的假设。我们的三个 目的验证以下假设:1)双TCRCD3等位基因表达通过干扰帧内等位基因转录和/或TCRCD3组装来调节TcR信号强度和功能T细胞活性;2)大多数NA�ve T细胞外周TcR修饰性是由强TcR信号诱导的;3)在急、慢性感染(流感和巨细胞病毒)中,双等位基因表达和修饰性都是T细胞最佳活性所必需的。这些研究结合了一套新的体外技术和体内模型,将导致对如何产生和调节最佳抗病毒T细胞反应的新理解,对我们理解获得性免疫具有广泛的意义。
英文摘要
DESCRIPTION (provided by applicant): In contrast to B cells, the T cell receptor repertoire is generally considered fixed once fully mature T cells exit the thymus. We recently developed the technology to detect and sequence the message of paired �� T cell receptors from single cells in mice and humans. This approach permitted two important observations: 1) the proportion of cells transcribing message for two Tcra chains varies dramatically over the course of acute and memory immune responses and 2) clonal lineages of T cells in vivo demonstrate evidence of receptor revision in the periphery. Using innovative in vitro single cell culture platforms, unique in vivo models including conditional RAG-deficient mice, and a valuable panel of longitudinal human samples, we propose to extend these observations to assess the hypothesis that optimal T cell responses to viral infections require an inherently plastic peripheral repertoire. Our three aims test the specific hypotheses that 1) Dual TCR� allele expression regulates TCR signal strength and functional T cell activity by interfering with in frame allele transcription and/or TCR:CD3 assembly, 2) Peripheral TCR revision is induced in most na�ve T cells by strong TCR signaling and 3) Both dual allele expression and revision are required for optimal T cell activity in acute and chronic infections (influenza and mCMV). These studies combine a suite of novel in vitro technology and in vivo models that will result in a new understanding of how optimal antiviral T cell responses are generated and regulated, with broad implications for our understanding of adaptive immunity.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fimmu.2018.01071
发表时间: 2018
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Souquette A, Thomas PG]
通讯作者: Thomas PG
DOI: 10.1371/journal.ppat.1004642
发表时间: 2015-02
期刊: PLoS pathogens
影响因子: 6.7
作者: [Duan S, Meliopoulos VA, McClaren JL, Guo XZ, Sanders CJ, Smallwood HS, Webby RJ, Schultz-Cherry SL, Doherty PC, Thomas PG]
通讯作者: Thomas PG
DOI: 10.4049/jimmunol.1701413
发表时间: 2018-01-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Zamora AE, Crawford JC, Thomas PG]
通讯作者: Thomas PG
Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells.
严重 H7N9 疾病的恢复与 CD8 T 细胞主导的多种反应机制有关
DOI: 10.1038/ncomms7833
发表时间: 2015-05-13
期刊: NATURE COMMUNICATIONS
影响因子: 16.6
作者: [Wang, Zhongfang, Wan, Yanmin, Qiu, Chenli, Quinones-Parra, Sergio, Zhu, Zhaoqin, Loh, Liyen, Tian, Di, Ren, Yanqin, Hu, Yunwen, Zhang, Xiaoyan, Thomas, Paul G., Inouye, Michael, Doherty, Peter C., Kedzierska, Katherine, Xu, Jianqing]
通讯作者: Xu, Jianqing
共 8 条
    Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
    • 批准号:
      10609918
    • 项目类别:
    • 资助金额:
      $70.3万
    • 财政年份:
      2023
    • 负责人:
      Paul G. Thomas
    • 依托单位:
    Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
    • 批准号:
      10467512
    • 项目类别:
    • 资助金额:
      $73.33万
    • 财政年份:
      2022
    • 负责人:
      Paul G. Thomas
    • 依托单位:
    Decoding the interactions between T cell receptors and peptide-MHC
    DECODING THE INTERACTIONS BETWEEN T CELL RECEPTORS AND PEPTIDE-MHC
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
    • 批准号:
      2025JJ70209
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      雷芬芳
    • 依托单位:
    AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      万荣
    • 依托单位: